Showing results (11-20 of 579) with videos related to
Sort By:
Pageof 58
International Journal of Cancer|March 10, 2001
TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosisJ Kamarashev, S Ferrone, B Seifert, et al.Journal of Cutaneous Pathology|August 1, 1996
T-cell receptor beta variable region (V beta) usage in cutaneous T-cell lymphomas (CTCL) in comparison to normal and eczematous skinN Potoczna, W H Boehncke, F O Nestle, et al.Blood|August 15, 1996
Sézary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain)R Dummer, P W Heald, F O Nestle, et al.Archives of Dermatological Research|July 27, 1999
Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD7- T lymphocyte subsets in Sézary syndromeR Dummer, F O Nestle, E Niederer, et al.Melanoma Research|February 6, 2002
Histological, immunological and molecular features of a nasal mucosa primary melanoma associated with nasal melanosisG F L Hofbauer, R Böni, D Simmen, et al.Nature Medicine|March 21, 1998
Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cellsF O Nestle, S Alijagic, M Gilliet, et al.Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 30, 2000
[Sporotrichoid infection with Mycobacterium marinum: successful therapy with oral tetracycline administration]G F Hofbauer, G Burg, F O NestleDermatology (Basel, Switzerland)|January 1, 1995
Dermatofibroma: an abortive immunoreactive process mediated by dermal dendritic cells?F O Nestle, B J Nickoloff, G BurgDermatology (Basel, Switzerland)|November 30, 2000
Cocaine-related Stevens-Johnson syndromeG F Hofbauer, G Burg, F O NestleClinical Lymphoma|November 15, 2001
Historical perspective on the use of retinoids in cutaneous T-cell lymphoma (CTCL)G Burg, R DummerPageof 58